semaglutide sglt2 inhibitor Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD SGLT2 Inhibitors and GLP-1 Receptor

Naturally, this means that some patients will prefer to take one treatment over the other, so if you think a longer or shorter-acting GLP-1 would be a better fit, you should discuss it in more detail with your prescriber

Another Novo Nordisk semaglutide drug, Wegovy, is FDA-approved for weight loss and has proven more effective in causing clinically significant weight loss than Saxendas active ingredient, liraglutide

Current management of chronic kidney disease in type-2 diabetes-A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD-UKKA) guidelines

Disclaimer: Individual results vary

Semaglutide and tirzepatide are different medicines, so dosing is not directly interchangeable